Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation

Spectroscopic, electronic structure, molecular docking, and molecular dynamics simulation study of 7-Trifluoromethyl-1H-indole-2-carboxylic acid as an aromatase inhibitor

The present work encompasses a combined experimental and theoretical investigation of the molecular structure, vibrational wavenumbers, electronic structure at the ground and electronic excited states, molecular electrostatic potential surface of 7-(Trifluoromethyl)-1H-indole-2-carboxylic acid (TICA) and possibility of the title molecule as an aromatase inhibitor using molecular docking and molecular dynamic simulations. A stable conformer has been obtained using potential energy scans by varying appropriate dihedral angles. The obtained minimum energy conformer was further optimized at the 6-311++G (d, p) basis set by applying the most accepted B3LYP functional. A good agreement between experimental and calculated normal modes of vibration has been observed. The hydrogen-bonded interaction between two monomeric units of TICA has been investigated using NBO,QTAIM, and NCI (noncovalent interactions) analysis. Molecular docking of TICA with human placental aromatase (PDB ID: 3S79) reveals the formation of polar hydrogen bonds as well as hydrophobic interactions between the ligand and the protein, right in the binding cavity. TICA satisfies all pharmacokinetic filters (Lipinski rule of five, the Veber rule, Ghose rule, Egan rule, as well as the Muegge rule) and has a high bioavailability score of 0.85. Dynamic stability of the ligand within the binding pocket of the target protein has been confirmed by 100 ns molecular dynamics simulation results. The present study provides an excellent starting point for additional in vivo research, and TICA may eventually serve as a significant therapeutic candidate for the treatment of breast cancer.

Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer

Novel agents are required to increase the radiosensitivity of cancer and improve the outcome of radiotherapy. Thioredoxin (Trx) and thioredoxin reductase (TrxR) reduce the oxidized cysteine thiols in several proteins, which regulate cellular redox, survival, proliferation, DNA synthesis, transcription factor activity and apoptosis. TrxR is essential for maintaining a conducive redox state for tumor growth, survival and resistance to therapy. Therefore, it is an appealing pharmacological target for the radiosensitization of tumors. Ionizing radiation (IR) is known to cause cytotoxicity through ROS, oxidative stress and DNA damage. Inhibition of thioredoxin system augments IR induced oxidative stress and potentiates cytotoxic effects. However, TrxR also regulates several critical cellular processes in normal cells. Here, we highlight the pre-clinical research and pharmacological studies to surmise possible utility of different TrxR inhibitors for radiosensitization. This review provides a succinct perspective on the role of TrxR inhibitors during the radiotherapy of cancer.

Hetero- and homoleptic binuclear gold(I)-thiolate and -halide complexes - ligand exchange kinetics and supramolecular structures

Heteroleptic and homoleptic binuclear Au(I) complexes [Au2(μ-PAnP)(SPh)(X)] (X = Cl^- or Br^-), [Au2(μ-PAnP)(SPh)2] and [Au2(μ-PAnP)(SPhCO2H)2] (SPh = benzenethiolate and SPhCO₂H = 4-thiolatobenzoic acid) containing the bridging diphosphine, 9,10-bis(diphenylphosphino)anthracene (PAnP), were synthesized and characterized by single crystal X-ray diffraction. [Au2(μ-PAnP)(SPh)2] exists as a monomer in its crystals but [Au2(μ-PAnP)(SPhCO2H)2] polymerizes into zig-zag chains via intermolecular hydrogen bonding. [Au2(μ-PAnP)(SPh)(Cl)] forms cyclophane-like dimers of C_i symmetry in crystals via intermolecular aurophilic interactions (Au-Au distance = 3.3081(5) Å). Recrystallization of [Au2(μ-PAnP)(SPh)(Br)] invariably led to crystals composed of [Au2(μ-PAnP)(SPh)(Br)] and [Au2(μ-PAnP)(Br)2]. Despite the chemically different P atoms in the heteroleptic [Au2(μ-PAnP)(SPh)(Cl)] and [Au2(μ-PAnP)(SPh)(Br)], solutions of the complexes show only a single signal in their ³¹P{¹H} NMR spectra at room temperature which resolved into two singlets of equal intensity at 183 K. Identical signals which show the same thermal behavior were observed in solutions of [Au2(μ-PAnP)(SPh)2] and [Au2(μ-PAnP)(X)2] in 1 : 1 molar ratios, indicating that there are three exchanging species, [Au2(μ-PAnP)(SPh)(X)], [Au2(μ-PAnP)(SPh)2] and [Au2(μ-PAnP)(X)2], in solution. A solution of [Au2(μ-PAnP)(Cl)2] and [Au2(μ-PAnP)(Br)2] in 1 : 1 molar ratio shows two singlets, implying that the exchange is not due to the dissociation of either PAnP or halide ligands, but rather it involves the exchange of the thiolate and the halide ligands (SPh^- ↔ X^-). A mixture of [(PPh3)Au(SPh)] and [(PPh3)Au(Cl)] (1 : 1 molar ratio) showed only one signal in its room temperature ³¹P{¹H} NMR spectrum, indicating that the ligand exchange can happen intermolecularly. Self-exchange of SPh^- ligands is possible as the room temperature ³¹P NMR spectrum of a mixture of [Au2(μ-PAnP)(SPh)2] and [Au2(μ-PAnP)(SPhCO2H)2] displayed only one signal. The rate constants of the exchange were determined by fitting the line shapes of the ³¹P NMR signals at different temperatures. The activation energies (E_as), obtained from Arrhenius plots, for the SPh^- ↔ Cl^- and SPh^- ↔ Br^- exchange are 36.9 ± 0.7 and 33.7 ± 1.0 kJ mol^-1, respectively. The activation enthalpy and activation entropy, obtained from Eyring plots, for the SPh^- ↔ Cl^- and SPh^- ↔ Br^- exchange are 35.0 ± 0.7 kJ mol^-1 and -25.7 ± 3.2 J K^-1, and 32.0 ± 1.0 kJ mol^-1 and -21.8 ± 4.7 J K^-1, respectively. Based on the kinetic results, two possible mechanisms were proposed for the reactions.

Transmetalation of boronic acids and their derivatives: mechanistic elucidation and relevance to catalysis

The Suzuki-Miyaura reaction (the cross-coupling reaction of boronic acids with organic halides catalysed by Pd complexes) has been recognised as a useful synthetic organic reaction that forms a C(sp²)-C(sp²) bond. The catalytic cycle of the reaction involves the transmetalation of aryl- and alkenylboronic acids with Pd(II) complexes. It migrates the aryl and alkenyl groups of boronic acid to Pd and produces a Pd-C bond. Many studies have investigated the mechanism of transmetalation. They elucidated the mechanism of the organometallic reaction and its role as a fundamental step in catalytic reactions. This perspective reviews studies on the transmetalation of aryl- and alkenylboronic acids with Pd(II) complexes. Emphasis was laid on the structures and chemical properties of the intermediate Pd complexes and the effects of OH^- on the pathways of the catalytic Suzuki-Miyaura reaction. The reactions of arylboronic acids with Rh(I)-OH complexes were investigated, which are relevant to the mechanism of Rh-catalysed addition of aryl boronic acids to enones and aldehydes. Recent studies on the transmetalation of boronic acids with other late transition metals such as Fe(II), Co(I), Pt(II), Au(III), and Au(I) are presented with the related catalytic reactions and their utilisation in the synthesis of aromatic molecules and π-conjugated materials.

Recent advances in the synthesis and derivatization of N-heterocyclic carbene metal complexes

N-heterocyclic carbene (NHC) metal complexes have gained an incredible amount of attention in the course of the last two decades and have become indispensable as an intricate part of a plethora of applications. The areas of their synthesis and derivatization are constantly evolving and bring new, more sustainable, cost-effective and simpler approaches to the design of existing and next generation catalysts and materials. This article provides an overview of the latest developments, focusing on those which have appeared during the last two years.

Continuous Flow Synthesis of [Au(NHC)(Aryl)] (NHC=N-Heterocyclic Carbene) Complexes

The use of weak and inexpensive bases has recently opened promising perspectives towards the simpler and more sustainable synthesis of Au(I)-aryl complexes with valuable applications in catalysis, medicinal chemistry, and materials science. In recent years, continuous manufacturing has shown to be a reliable partner in establishing sustainable and controlled process scalability. Herein, the first continuous flow synthesis of a range of Au(I)-aryl starting from widely available boronic acids and various [Au(NHC)Cl] (NHC=N-heterocyclic carbene) complexes in unprecedentedly short reaction times and high yields is reported. Successful synthesis of previously non- or poorly accessible complexes exposed fascinating reactivity patterns. Via a gram-scale synthesis, convenient process scalability of the developed protocol was showcased.

Mild and Efficient Synthesis of Diverse Organo-AuI -L Complexes in Green Solvents

An exceptionally mild and efficient method was developed for the preparation of (hetero)aryl-Au^I -L complexes using ethanol or water as the reaction medium at room temperature and Ar-B(triol)K boronates as the transmetalation partner. The reaction does not need an exogeneous base or other additives, and quantitative yields can be achieved through a simple filtration as the only required purification method, which obviates considerable waste associated with alternative workup methods. A broad reaction scope was demonstrated with respect to both the L and (hetero)aryl ligands on product Au complexes. Despite the polar reaction medium, large polycyclic aromatic hydrocarbon units can be incorporated on the Au complexes in very good to excellent yields. The approach was demonstrated for the chemoselective manipulation of orthogonally protected aryl boronates to afford a new class of N-heterocyclic carbene-Au-aryl complexes. A mechanistic rationale was proposed.

Simple Synthetic Routes to N-Heterocyclic Carbene Gold(I)-Aryl Complexes: Expanded Scope and Reactivity

The discovery of sustainable and scalable synthetic protocols leading to gold-aryl compounds bearing N-heterocyclic carbene (NHC) ligands sparked an investigation of their reactivity and potential utility as organometallic synthons. The use of a mild base and green solvents provide access to these compounds, starting from widely available boronic acids and various [Au(NHC)Cl] complexes, with reactions taking place under air, at room temperature and leading to high yields with unprecedented ease. One compound, (N,N'-bis[2,6-(di-isopropyl)phenyl]imidazol-2-ylidene)(4-methoxyphenyl)gold, ([Au(IPr)(4-MeOC₆ H₄ )]), was synthesized on a multigram scale and used to gauge the reactivity of this class of compounds towards C-H/N-H bonds and with various acids, revealing simple pathways to gold-based species that possess attractive properties as materials, reagents and/or catalysts.

Pharmacokinetics and Tissue Distribution of a Novel Bis-Chelated Gold(I) Diphosphine Compound, Bis(2,3-bis(tert-butylmethylphosphino)Quinoxaline)Aurate(I), in Rats

GC20, a novel soluble bis-chelated gold(I)−diphosphine compound, has been reported as a promising anticancer candidate. Assessing the pharmacokinetic properties of GC20 is critical for its medicinal evaluation. First, a sensitive and specific liquid chromatography tandem mass spectrometry (LC-MS/MS) was developed and well validated to determine GC20 in rat plasma and rat tissue homogenate after one step protein precipitation. Chromatographic separation was achieved on an Angilent ZORBAX-C18 column (3.5 μm, 2.1 × 50 mm) with gradient elution and mass spectrometry was performed on a triple quadrupole in positive ion mode using an electrospray ionization source. This method was then applied to investigate the pharmacokinetics and tissue distribution of GC20 in rats after intravenous administration. The results showed that the plasma exposure of GC20 in vivo increased with increasing doses after a single dose. However, after multiple doses, a significant accumulation and a saturation at elimination were observed for GC20 in rats. Moreover, after intravenous administration, GC20 was widely distributed in various tissues, with the highest levels in the lung, spleen, liver, and pancreas, followed by the kidney and heart, while the lowest level was found in the brain. This is the first report on the pharmacokinetic properties of GC20.

Bioactive and luminescent indole and isatin based gold(i) derivatives

Combination of bioactive indole and isatin derivatives with Au(i) affords highly cytotoxic metallic species even for cisplatin resistant leukemia cells (Jurkat-shBak).

Deactivation Routes in Gold(I) Polypyridyl Complexes: Internal Conversion Vs Fast Intersystem Crossing

An electronic spectral and photophysical characterization of three gold(I) complexes containing heterocyclic chromophores differing in the number and arrangement of pyridine rings (pyridine, bipyridine, and terpyridine, with the acronyms pD, bD, and tD respectively) was performed. Quantum yields of fluorescence, internal conversion and triplet state formation, together with the rate constants for singlet to triplet intersystem crossing, S₁ ∼ ∼ ∼ S₀ internal conversion and fluorescence were measured in order to equate the impact of fast triplet state formation on the amount of triplets formed. The results showed a correlation between the increase on the measured decay values of S₁ (leading to the main formation of T₁) and the increase in the charge transfer (CT) character of the lowest energy transition, as evaluated from the orthogonality of the frontier orbitals. The measured triplet state quantum yields range from ∼50-60% to 70%, whereas the intersystem crossing rate constants differ by almost 2 orders of magnitude, from 9.4 × 10⁹ s^-1 for tD to 8.1 × 10¹¹ s^-1 for bD. This constitutes an evidence for the existence of a correlation between the intersystem crossing and the internal conversion mechanisms.

Nonadiabatic dynamics simulations on internal conversion and intersystem crossing processes in gold(i) compounds

The position at which the second gold(i)-phosphine group is attached was experimentally found to play a noticeable role in intersystem crossing rates of gold(i) naphthalene derivatives. However, the physical origin is ambiguous. Herein we have employed generalized trajectory-based surface-hopping dynamics simulations to simulate the excited-state relaxation dynamics of these gold(i) naphthalene compounds including both the intersystem crossing process from the initially populated first excited singlet states S₁ to triplet manifolds and internal conversion processes within these triplet states. Our predicted intersystem crossing rates are consistent with experiments very well. On the basis of the present results, we have found that (1) ultrafast and subpicosecond intersystem crossing processes are mainly caused by small energy gaps and large spin-orbit couplings between S₁ and T_n; (2) adding the second gold(i)-phosphine group does not increase spin-orbit couplings between S₁ and T_n but decrease their values remarkably, which implies that heavy-atom effects are state-specific, not state-universal; (3) the position at which the second gold(i)-phosphine group is attached has a remarkable influence on the electronic structures of S₁ and T_n and their relative energies, which affect energy gaps and spin-orbit couplings between S₁ and T_n and eventually modulate intersystem crossing rates from S₁ to T_n. These new insights are very useful for the design of gold-containing compounds with excellent photoluminescence properties. Finally, this work also exemplifies that different isomers of a compound could have distinct excited-state relaxation dynamics.

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species

Auranofin (AF) is an anti-arthritic drug considered for combined chemotherapy due to its ability to impair the redox homeostasis in tumor cells. In this study, we asked whether AF may in addition radiosensitize tumor cells by targeting thioredoxin reductase (TrxR), a critical enzyme in the antioxidant defense system operating through the reductive protein thioredoxin. Our principal findings in murine 4T1 and EMT6 tumor cells are that AF at 3-10 μM is a potent radiosensitizer in vitro, and that at least two mechanisms are involved in TrxR-mediated radiosensitization. The first one is linked to an oxidative stress, as scavenging of reactive oxygen species (ROS) by N-acetyl cysteine counteracted radiosensitization. We also observed a decrease in mitochondrial oxygen consumption with spared oxygen acting as a radiosensitizer under hypoxic conditions. Overall, radiosensitization was accompanied by ROS overproduction, mitochondrial dysfunction, DNA damage and apoptosis, a common mechanism underlying both cytotoxic and antitumor effects of AF. In tumor-bearing mice, a simultaneous disruption of the thioredoxin and glutathione systems by the combination of AF and buthionine sulfoximine was shown to significantly improve tumor radioresponse. In conclusion, our findings illuminate TrxR in cancer cells as an exploitable radiobiological target and warrant further validation of AF in combination with radiotherapy.

Self-Assembled BODIPY-Based Iridium Metallarectangles: Cytotoxicity and Propensity to Bind Biomolecules

A new 4-ethynylpyridine 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-based ligand L, which was synthesized by means of the Sonogashira coupling method, was used to obtain two new [2+2] iridium-based metallarectangles, 3 and 4. Ligand L and metallarectangles 3 and 4 were fully characterized through various analytical techniques. The structure of rectangle 4 was further confirmed by single-crystal X-ray diffraction analysis, which showed the formation of an expected [2+2] supramolecule, in which the iridium metal centers were bridged with ligand L to form the desired metallarectangle 4. In the context of the growing biological interest in metallarectangles, rectangle 4 was found to be highly active against two types of cancer cells, with IC₅₀ values almost threefold superior to those of cisplatin. Both 3 and 4 showed dose-dependent abilities to bind bovine serum albumin and salmon sperm DNA; this indicated their tendency to interact with such biomolecules as a potential mode of action.

New insights in Au-NHCs complexes as anticancer agents

Within the research field of antitumor metal-based agents alternative to platinum drugs, gold(I/III) coordination complexes have always been in the forefront due mainly to the familiarity of medicinal chemists with gold compounds, whose application in medicine goes back in the ancient times, and to the rich chemistry shown by this metal. In the last decade, N-heterocyclic carbene ligands (NHC), a class of ligands that largely resembles the chemical properties of phosphines, became of interest for gold(I) medicinal applications, and since then, the research on NHC-gold(I/III) coordination complexes as potential antiproliferative agents boosted dramatically. Different classes of gold(I/III)-NHC complexes often showed an outstanding in vitro antiproliferative activity, however up to now very few in vivo data have been reported to corroborate the in vitro results. This review summarizes all achievements in the field of gold (I/III) complexes comprising NHC ligands proposed as potential antiproliferative agents in the period 2004-2016, and critically analyses biological data (mainly IC₅₀ values) in relation to the chemical structures of Au compounds. The state of art of the in vivo studies so far described is also reported.

Syntheses, structures and anti-tumor activity of four organotin(iv) dicarboxylates based on (1,3,4-thiadiazole-2,5-diyldithio)diacetic acid

Four novel organotin complexes, derived from flexible (1,3,4-thiadiazole-2,5-diyldithio)diacetic acid (H₂tzda), have been synthesized and characterized by elemental analysis, FT-IR, NMR and X-ray crystallography.

Syntheses, structures and anti-tumor activity of four new organotin(iv) carboxylates based on 2-thienylselenoacetic acid

With the 2-thienylselenoacetic acid ligand, four new organotin complexes have been synthesized and characterized by X-ray crystallography, elemental analysis, FT-IR and NMR (¹H,¹³C, and¹¹⁹Sn) spectroscopy.

A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer

Nucleoside transport is an essential process that helps maintain the hyperproliferative state of most cancer cells. As such, it represents an important target for developing diagnostic and therapeutic agents that can effectively detect and treat cancer, respectively. This report describes the development of a metal-containing nucleoside designated Ir(III)-PPY nucleoside that displays both therapeutic and diagnostic properties against the human epidermal carcinoma cell line KB3-1. The cytotoxic effects of Ir(III)-PPY nucleoside are both time- and dose-dependent. Flow cytometry analyses validate that the nucleoside analog causes apoptosis by blocking cell cycle progression at G2/M. Fluorescent microscopy studies show rapid accumulation in the cytoplasm within 4 h. However, more significant accumulation is observed in the nucleus and mitochondria after 24 h. This localization is consistent with the ability of the metal-containing nucleoside to influence cell cycle progression at G2/M. Mitochondrial depletion is also observed after longer incubations (Δt ∼48 h), and this effect may produce additional cytotoxic effects. siRNA knockdown experiments demonstrate that the nucleoside transporter, hENT1, plays a key role in the cellular entry of Ir(III)-PPY nucleoside. Collectively, these data provide evidence for the development of a metal-containing nucleoside that functions as a combined therapeutic and diagnostic agent against cancer.

Cyclometalated (boroxinato)gold(iii) complexes from arrested transmetalation

Luminescent metallaboroxines of gold(iii) form in self-assembly reactions from trifluoroacetato precursors and alkyl or arylboronic acids.

Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities

A series of gold(I) complexes involving triphenylphosphine (PPh₃) and one N-donor ligand derived from deprotonated mono- or disubstituted hypoxanthine (HL_n) of the general composition [Au(L_n)(PPh₃)] (1–9) is reported. The complexes were thoroughly characterized, including multinuclear high resolution NMR spectroscopy as well as single crystal X-ray analysis (for complexes 1 and 3). The complexes were screened for their invitro cytotoxicity against human cancer cell lines MCF7 (breast carcinoma), HOS (osteosarcoma) and THP-1 (monocytic leukaemia), which identified the complexes 4–6 as the most promising representatives, who antiproliferative activity was further tested against A549 (lung adenocarcinoma), G-361 (melanoma), HeLa (cervical cancer), A2780 (ovarian carcinoma), A2780R (ovarian carcinoma resistant to cisplatin), 22Rv1 (prostate cancer) cell lines. Complexes 4–6 showed a significantly higher invitro anticancer effect against the employed cancer cells, except for G-361, as compared with the commercially used anticancer drug cisplatin, with IC₅₀ ≈ 1–30 µM. Anti-inflammatory activity was evaluated invitro by the assessment of the ability of the complexes to modulate secretion of the pro-inflammatory cytokines, i.e. tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), in the lipopolysaccharide-activated macrophage-like THP-1 cell model. The results of this study identified the complexes as auspicious anti-inflammatory agents with similar or better activity as compared with the clinically applied gold-based antiarthritic drug Auranofin. In an effort to explore the possible mechanisms responsible for the biological effect, the products of interactions of selected complexes with sulfur-containing biomolecules (L-cysteine and reduced glutathione) were studied by means of the mass-spectrometry study.

Spectroscopic (FT-IR, FT-Raman, and UV-visible) and quantum chemical studies on molecular geometry, Frontier molecular orbitals, NBO, NLO and thermodynamic properties of 1-acetylindole

Quantum chemical calculations of ground state energy, geometrical structure and vibrational wavenumbers of 1-acetylindole were carried out using density functional (DFT/B3LYP) method with 6-311++G(d,p) basis set. The FT-IR and FT-Raman spectra were recorded in the condensed state. The fundamental vibrational wavenumbers were calculated and a good correlation between experimental and scaled calculated wavenumbers has been accomplished. Electric dipole moment, polarizability and first static hyperpolarizability values of 1-acetylindole have been calculated at the same level of theory and basis set. The results show that the 1-acetylindole molecule possesses nonlinear optical (NLO) behavior with non-zero values. Stability of the molecule arising from hyper-conjugative interactions and charge delocalization has been analyzed using natural bond orbital (NBO) analysis. UV-Visible spectrum of the molecule was recorded in the region 200-500nm and the electronic properties like HOMO and LUMO energies and composition were obtained using TD-DFT method. The calculated energies and oscillator strengths are in good correspondence with the experimental data. The thermodynamic properties of the compound under investigation were calculated at different temperatures.

Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways

X-ray-based radiotherapy represents one of the most effective ways in treating human cancers. However, radioresistance and side effect remain as the most challenging issue. This study describes the design and application of novel selenadiazole derivatives as radiotherapy sensitizers to enhance X-ray-induced inhibitory effects on A375 human melanoma and Hela human cervical carcinoma cells. The results showed that, pretreatment of the cells with selenadiazole derivatives dramatically enhance X-ray-induced growth inhibition and colony formation. Flow cytometry analysis indicates that the sensitization by selenadiazole derivatives was mainly caused by induction of G2/M cell cycle arrest. Results of Western blotting demonstrated that the combined treatment-induced A375 cells growth inhibition was achieved by triggering reactive oxygen species-mediated DNA damage involving inactivation of AKT and MAPKs. Further investigation revealed that selenadiazole derivative in combination with X-ray could synergistically inhibit the activity of thioredoxin reductase-1 in A375 cells. Taken together, these results suggest that selenadiazole derivatives can act as novel radiosensitizer with potential application in combating human cancers.